The Allopharm company received a registration certificate for the original medical product ENTOMIX®
The Allopharm company received a registration certificate for the original [...]
Allostatin® has been successfully tested against pancreatic cancer in South Korea
In early 2019, a South Korean company received the rights [...]
Allopharm was the organizer of an international meeting of scientists and entrepreneurs
On September a meeting between representatives of science and business [...]
Allopharm developments have attracted the interest of the scientific community of South Korea
A meeting with our foreign colleagues took place in Seoul [...]
Scientists have found a way to extend the era of antibiotics
The report about a new discovery of our scientist has [...]
The international scientific journal «Infection and Drug Resistance» published an article about «Allopharm» developements
The article «Biofilm infections between Scylla and Charybdis: interaction of [...]